Product

HS-10384

Aliases

HS-10384-matched placebo tablets, HS-10384 tablets

2 clinical trials

1 indication

Indication

Vasomotor Symptoms

Clinical trial

A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HS-10384 in Chinese Postmenopausal Women

Status: Recruiting, Estimated PCD: 2024-06-30

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study to Investigate the Efficacy and Safety of HS-10384 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)

Status: Not yet recruiting, Estimated PCD: 2025-06-30